Patents by Inventor Mark Hyman, Jr.

Mark Hyman, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5572314
    Abstract: A Brewster angle refractometer, based on the principal that reflectivity of light polarized parallel to the plane of incidence is minimized at the Brewster angle, is used to determine the refractive index of a material. The refractometer has a precision mechanical drive arrangement for precisely determining the refractive index over a range of 1.4 to 3.0, with an accuracy of at least .+-.0.02.
    Type: Grant
    Filed: September 19, 1994
    Date of Patent: November 5, 1996
    Inventors: Mark Hyman, Jr., Cornelius S. Hurlbut
  • Patent number: 4017738
    Abstract: A new scintillator, di-m-methylphenyl-1,3,4-oxadiazole, or 2,5-di-m-tolyl-1,3,4-oxadiazole, is prepared by reacting m-toluoyl chloride with hydrazine to form di-m-toluoyl hydrazine which, in turn, is reacted with thionyl chloride to form the desired product. The scintillator, di-m-methylphenyloxadiazole compares favorably with present commercial products, being equal to or better than diphenyloxazole in most important respects and significantly superior in scintillation pulse height and in stability. It can be produced at a fraction of the cost of today's most widely used product.
    Type: Grant
    Filed: June 17, 1975
    Date of Patent: April 12, 1977
    Inventor: Mark Hyman, Jr.
  • Patent number: 3951847
    Abstract: A new scintillator composition, consisting essentially of di-m-methylphenyl-1,3,4-oxadiazole, or 2,5-di-m-tolyl-1,3,4-oxadiazole, is prepared by reacting m-toluoyl chloride with hydrazine to form di-m-toluoyl hydrazine which, in turn, is reacted with thionyl chloride to form the desired product which is dissolved in an organic solvent. The scintillator, di-m-methylphenyloxadiazole compares favorably with present commercial products, being equal to or better than diphenyloxazole in most important respects and significantly superior in scintillation pulse height and in stability. It can be produced at a fraction of the cost of today's most widely used product.
    Type: Grant
    Filed: June 26, 1974
    Date of Patent: April 20, 1976
    Inventor: Mark Hyman, Jr.